-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-5%Rx only
Shaigan
Eliquis Tablets
Rated 3.5 out of 5 (4)SKU HP-06655
A tablet containing Apixaban, indicated for Stroke.
Rs. 2,265Rs. 2,385-5%
You save Rs. 120
250ml Shampoo
In StockSet your city for an exact delivery date
In stock at selected branches
Prescription required
A licensed pharmacist will verify your prescription and call you within 15 minutes before this is dispensed.
Upload your prescriptionQuantity
Eliquis Tablets quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 2,265
What it is used for: Stroke.
Indications as listed by the manufacturer: Apixaban is indicated for: • The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery. • The prevention of stroke and systemic embolism in patients with atrial fibrillation. • The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
How it works: Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa and prothrombinase activity. Apixaban has no direct effects on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting factor Xa, Apixaban prevents thrombin generation and thrombus development.
Active ingredient: Apixaban.
Reported side effects: Common: Haemorrhage, haematoma, epistaxis, gastrointestinal haemorrhage, rectal haemorrhage, gingival bleeding, haematuria and contusion. Uncommon: Pruritus, eye haemorrhage (including conjunctival haemorrhage), haemoptysis, haematochezia, abnormal vaginal haemorrhage, urogenital haemorrhage, occult blood positive, traumatic haemorrhage, post procedural haemorrhage and incision site haemorrhage. Rare: Brain haemorrhage and respiratory tract haemorrhage .
Known drug interactions: Inhibitors of CYP3A4 and P-gp , g. Inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) , thrombolytic agents, fibrinolytics, GPIIb/IIIa receptor antagonists, thienopyridines (e.g., clopidogrel), dipyridamole, dextran, heparin, aspirin, chronic NSAID and sulfinpyrazone.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Prevention of stroke and systemic embolism in patients with atrial fibrillation : The recommended dose of Apixaban for most patients is 5mg taken orally twice daily. The recommended dose of Apixaban is 2.5mg twice daily in patients with at least two of the following characteristics: • age greater than or equal to 80 years • body weight less than or equal to 60 kg • serum creatinine greater than or equal to 1.5mg/dL . Prevention of venous thromboembolic events (VTE) following Hip or Knee Replacement Surgery : The recommended dose of Apixaban is 2.5mg taken orally twice daily . Treatment of DVT and PE and Prevention of recurrent DVT and PE : The recommended dose of Apixaban is 10mg taken orally twice daily for 7 days, followed by 5mg taken orally twice daily for the treatment of acute DVT or PE . OR As directed by your physician .
Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.
Active ingredient: Apixaban. Labelled strength: 5mg.
- Apixaban is contraindicated in: • Hypersensitivity to the active substance or to any of the excipient of the product. • Active clinically significant bleeding including GI bleeding. • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. • Lesion or condition if considered a significant risk factor for major bleeding e.g., current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. • Concomitant systemic treatment with HIV protease inhibitors, e.g., ritonavir.
- Premature discontinuation of any oral anticoagulant, including Apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if Apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
- Epidural or spinal hematomas may occur in patients treated with Apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.
- Apixaban increases the risk of bleeding and can cause serious, potentially fatal, bleeding. Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room. Discontinue Apixaban in patients with active pathological hemorrhage .
- The safety and efficacy of Apixaban have not been studied in patients with prosthetic heart valves. Therefore, use of Apixaban is not recommended in these patients.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Eliquis Pharmaceuticals (Pvt) Ltd.. Country of origin: Germany.
3.5
Rated 3.5 out of 54 verified ratings
- 5★0%
- 4★83%
- 3★17%
- 2★0%
- 1★0%
- Shahid Hussain4 Aug 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Adnan Yousuf25 Jul 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Lahore the next day.
- Komal J.Verified Purchase17 Jul 2026Rated 4.0 out of 5
Product is fine and authentic. Delivery took a day longer than the slot I picked.
- Ayesha K.Verified Purchase29 Jun 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Rabia N.23 Jun 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Imran Q.Verified Purchase31 May 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Faisalabad the next day.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Stroke.
Indications as listed by the manufacturer: Apixaban is indicated for: • The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery. • The prevention of stroke and systemic embolism in patients with atrial fibrillation. • The treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention of recurrent DVT and PE.
How it works: Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa and prothrombinase activity. Apixaban has no direct effects on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting factor Xa, Apixaban prevents thrombin generation and thrombus development.
Active ingredient: Apixaban.
Reported side effects: Common: Haemorrhage, haematoma, epistaxis, gastrointestinal haemorrhage, rectal haemorrhage, gingival bleeding, haematuria and contusion. Uncommon: Pruritus, eye haemorrhage (including conjunctival haemorrhage), haemoptysis, haematochezia, abnormal vaginal haemorrhage, urogenital haemorrhage, occult blood positive, traumatic haemorrhage, post procedural haemorrhage and incision site haemorrhage. Rare: Brain haemorrhage and respiratory tract haemorrhage .
Known drug interactions: Inhibitors of CYP3A4 and P-gp , g. Inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John’s wort) , thrombolytic agents, fibrinolytics, GPIIb/IIIa receptor antagonists, thienopyridines (e.g., clopidogrel), dipyridamole, dextran, heparin, aspirin, chronic NSAID and sulfinpyrazone.
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Prescription verified by a pharmacist before your order is dispatched
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Prevention of stroke and systemic embolism in patients with atrial fibrillation : The recommended dose of Apixaban for most patients is 5mg taken orally twice daily. The recommended dose of Apixaban is 2.5mg twice daily in patients with at least two of the following characteristics: • age greater than or equal to 80 years • body weight less than or equal to 60 kg • serum creatinine greater than or equal to 1.5mg/dL . Prevention of venous thromboembolic events (VTE) following Hip or Knee Replacement Surgery : The recommended dose of Apixaban is 2.5mg taken orally twice daily . Treatment of DVT and PE and Prevention of recurrent DVT and PE : The recommended dose of Apixaban is 10mg taken orally twice daily for 7 days, followed by 5mg taken orally twice daily for the treatment of acute DVT or PE . OR As directed by your physician .
Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.
Active ingredient: Apixaban. Labelled strength: 5mg.
- Apixaban is contraindicated in: • Hypersensitivity to the active substance or to any of the excipient of the product. • Active clinically significant bleeding including GI bleeding. • Hepatic disease associated with coagulopathy and clinically relevant bleeding risk. • Lesion or condition if considered a significant risk factor for major bleeding e.g., current or recent gastrointestinal ulceration, presence of malignant neoplasms at high risk of bleeding, recent brain or spinal injury, recent brain, spinal or ophthalmic surgery, recent intracranial haemorrhage, known or suspected oesophageal varices, arteriovenous malformations, vascular aneurysms or major intraspinal or intracerebral vascular abnormalities. • Concomitant systemic treatment with HIV protease inhibitors, e.g., ritonavir.
- Premature discontinuation of any oral anticoagulant, including Apixaban, increases the risk of thrombotic events. To reduce this risk, consider coverage with another anticoagulant if Apixaban is discontinued for a reason other than pathological bleeding or completion of a course of therapy.
- Epidural or spinal hematomas may occur in patients treated with Apixaban who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis. Consider these risks when scheduling patients for spinal procedures.
- Apixaban increases the risk of bleeding and can cause serious, potentially fatal, bleeding. Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room. Discontinue Apixaban in patients with active pathological hemorrhage .
- The safety and efficacy of Apixaban have not been studied in patients with prosthetic heart valves. Therefore, use of Apixaban is not recommended in these patients.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Eliquis Pharmaceuticals (Pvt) Ltd.. Country of origin: Germany.
3.5
Rated 3.5 out of 54 verified ratings
- 5★0%
- 4★83%
- 3★17%
- 2★0%
- 1★0%
- Shahid Hussain4 Aug 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Adnan Yousuf25 Jul 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Lahore the next day.
- Komal J.Verified Purchase17 Jul 2026Rated 4.0 out of 5
Product is fine and authentic. Delivery took a day longer than the slot I picked.
- Ayesha K.Verified Purchase29 Jun 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Rabia N.23 Jun 2026Rated 4.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
- Imran Q.Verified Purchase31 May 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Faisalabad the next day.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
ShaiganEliquis TabletsRs. 2,265Rated 3.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 5,250Rs. 5,615
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
